Showing results (51-60 of 345) with videos related to
Sort By:
Pageof 35
Molecular Pharmacology|October 13, 2005
Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2Girija Dasmahapatra, Jorge A Almenara, Steven GrantClinical Lymphoma, Myeloma & Leukemia|October 22, 2017
Blood Transfusion Management and Transfusion-Related Outcomes in Daratumumab-Treated Patients With Relapsed or Refractory Multiple MyelomaAjai Chari, Suzanne Arinsburg, Sundar Jagannath, et al.Blood|January 11, 2003
Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cellsShujie Wang, Zhiliang Wang, Paul Dent, et al.Cancer Treatment Reviews|January 9, 2010
Exploiting cellular pathways to develop new treatment strategies for AMLAmir T Fathi, Steven Grant, Judith E KarpEmergency Medicine Australasia : EMA|March 4, 2009
How would Australian hospital staff react to an avian influenza admission, or an influenza pandemic?Franco Martinese, Gerben Keijzers, Steven Grant, et al.Blood Reviews|August 21, 2022
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectivesIan M Bouligny, Keri R Maher, Steven GrantJournal of Cellular Signaling|March 13, 2023
Augmenting Venetoclax Activity Through Signal Transduction in AMLIan Michael Bouligny, Keri Renee Maher, Steven GrantClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cellsChunrong Yu, Geoffrey Krystal, Paul Dent, et al.Molecular and Cellular Biology|June 21, 2005
Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activationYun Dai, Mohamed Rahmani, Paul Dent, et al.Cancer Biology & Therapy|February 9, 2012
Enhancing CHK1 inhibitor lethality in glioblastomaYong Tang, Yun Dai, Steven Grant, et al.Pageof 35